Results and presentations

Latest results announcements and presentations


AstraZeneca Investor Science Event at ERS 2017

2 Downloads available



Majority stake investment in Acerta Pharma

2 Downloads available

Late-stage pipeline call

1 Download available

American College of Rheumatology (ACR) 2015 Investor science conference call

2 Downloads available

Acquisition of ZS Pharma

1 Download available


European Society for Medical Oncology (ESMO) 2014

3 Downloads available



Fostamatinib analyst briefing

2 Downloads available

Fostamatinib analyst briefing video

Play Video

Naloxegol educational presentation

2 Downloads available

Naloxegol educational presentation video

Play Video

R&D Roundtable

1 Download available

30th Annual J.P. Morgan Healthcare Conference

1 Download available

Upcoming events

Debt investor update, US

Payment date: second interim dividend

SEC filings

SEC filings are those documents that we are required to file by virtue of our listing on the New York Stock Exchange. They contain mainly financial information.

These documents are also available for viewing on the SEC website at The Company will send any holder of the Company’s securities, upon request, a hard copy of the Company’s complete audited financial statements free of charge. Requests may be made by writing to:

Company Secretary
AstraZeneca PLC
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 0AA

Annual reports

Investor enquiries

Main Contacts

Thomas Kudsk Larsen

Craig Marks

Finance, Fixed Income, M&A

Henry Wheeler


Mitchell Chan

Oncology; Other

Nick Stone

Respiratory; Renal

Christer Gruvris

Brilinta; Diabetes

US general enquiries